Apimeds Pharmaceuticals US, Inc. (APUS) Announces February 21st IPO
Apimeds Pharmaceuticals US, Inc. (APUS) expects to raise $20 million in an initial public offering (IPO) on Friday, February 21st, IPO Scoop reports. The company will issue 4,500,000 shares at $4.00-$5.00 per share. The company has a market-cap of $40.3 million. Apimeds Pharmaceuticals US provided the following description of their company for its IPO: “We […]
Apimeds Pharmaceuticals US, Inc. (APUS) expects to raise $20 million in an initial public offering (IPO) on Friday, February 21st, IPO Scoop reports. The company will issue 4,500,000 shares at $4.00-$5.00 per share. The company has a market-cap of $40.3 million. Apimeds Pharmaceuticals US provided the following description of their company for its IPO: “We […]
